Drugs / HP-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07811986 | Sep 2026 → Dec 2027 expected | plasma cell myeloma | Institute of Hematology & Blood Diseases Hospital, China | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HP-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07811986 ↗ |
| Route | Oral | “administered orally” NCT07811986 ↗ |